Trial Profile
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenecteplase (Primary) ; Alteplase
- Indications Stroke
- Focus Therapeutic Use
- Acronyms ATTEST 2
- 21 Feb 2020 Recruitment as of November 6th 2019 is 784 as per trial design released at the International Stroke Conference 2020.
- 21 Feb 2020 Trial design presented at the International Stroke Conference 2020
- 08 Feb 2019 Trial design presented at the International Stroke Conference 2019